ARCHIVES

Berlin, DeVita Differ On Use Of L-PAM

This article is from The Cancer Letter archive.

Vol. 01 No. 40 | November 8, 1974

Download PDF Visit The Full Archive

Related Articles

FDA Committee IK IL-2/LAK For Modified Group C

May 1, 1987

In Brief: Schepartz To Leave NCI for Academia; Woolley Names To Head Clinical Research At Lombardi

March 9, 1984

Sen. Grassley Presses Amgen on “Bundling.”

April 11, 2008

UCLA Comp Center status Near, But There Are Problems

October 22, 1976

Why Four? NCI Official Challenged To Explain Rational For Proposed Number Of Groups

March 25, 2011

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989